Centric Health Corp. (TSE:CRX – Free Report) – Equities research analysts at Desjardins dropped their FY2024 earnings per share (EPS) estimates for Centric Health in a research note issued on Sunday, November 10th. Desjardins analyst G. Ho now anticipates that the company will post earnings of ($0.03) per share for the year, down from their prior estimate of ($0.02).
A number of other brokerages have also issued reports on CRX. Ventum Cap Mkts upgraded shares of Centric Health to a “strong-buy” rating in a research report on Thursday, August 8th. Stifel Canada downgraded shares of Centric Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 12th.
Centric Health Price Performance
Further Reading
- Five stocks we like better than Centric Health
- Business Services Stocks Investing
- 3 GARP Stocks Offering Strong Growth: Aptiv, Allstate, Barrick
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Mouse Rising: The Iger Investment Pays Off for Disney Investors
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Can CAVA Stock Be the Next Chipotle? Earnings Can Help
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
